Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Sinclair

Showing results (191-200 of 256) with videos related to

Pageof 26
Sort By:
Journal of Cosmetic Dermatology|July 3, 2019
Novel shampoo reduces hair shedding by contracting the arrector pili muscle via the trace amine-associated receptorMaja Kovacevic, John McCoy, Andy Goren, et al.
Archives of Dermatological Research|December 10, 2024
Indonesian dreadlock hair: a novel presentation of hair shaft disordersAgnes Rosarina Prita Sari, Wan Gifanni Efmadian Shelly, Nadia Nur Asifa, et al.
Dermatology and Therapy|November 22, 2023
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia AreataMaryanne M Senna, Ohsang Kwon, Bianca M Piraccini, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 24, 2022
Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a TrialBrett King, Emma Guttman-Yassky, Elena Peeva, et al.
Nature Reviews. Disease Primers|November 6, 2025
Alopecia areataBenjamin Ungar, Yael Renert-Yuval, Ncoza C Dlova, et al.
Journal of the American Academy of Dermatology|November 28, 2025
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, et al.
Dermatology and Therapy|April 16, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based ApproachBrett King, Maryanne Senna, Manabu Ohyama, et al.
Journal of Cosmetic Dermatology|April 26, 2020
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?John McCoy, Carlos G Wambier, Sergio Vano-Galvan, et al.
Clinics in Dermatology|May 11, 2021
Shedding light on therapeutics in alopecia and their relevance to COVID-19Nicole Fagan, Nekma Meah, Katherine York, et al.
The Australasian Journal of Dermatology|May 11, 2026
Alopecia Areata Prevalence in Australia: Insights From a Nationally Representative Cross-Sectional Survey StudyRodney Sinclair, Samantha Eisman, Leona Yip, et al.
Pageof 26

Showing results (191-200 of 256) with videos related to

Sort By:
Pageof 26
Journal of Cosmetic Dermatology|July 3, 2019
Novel shampoo reduces hair shedding by contracting the arrector pili muscle via the trace amine-associated receptorMaja Kovacevic, John McCoy, Andy Goren, et al.
Archives of Dermatological Research|December 10, 2024
Indonesian dreadlock hair: a novel presentation of hair shaft disordersAgnes Rosarina Prita Sari, Wan Gifanni Efmadian Shelly, Nadia Nur Asifa, et al.
Dermatology and Therapy|November 22, 2023
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia AreataMaryanne M Senna, Ohsang Kwon, Bianca M Piraccini, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 24, 2022
Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a TrialBrett King, Emma Guttman-Yassky, Elena Peeva, et al.
Nature Reviews. Disease Primers|November 6, 2025
Alopecia areataBenjamin Ungar, Yael Renert-Yuval, Ncoza C Dlova, et al.
Journal of the American Academy of Dermatology|November 28, 2025
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, et al.
Dermatology and Therapy|April 16, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based ApproachBrett King, Maryanne Senna, Manabu Ohyama, et al.
Journal of Cosmetic Dermatology|April 26, 2020
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?John McCoy, Carlos G Wambier, Sergio Vano-Galvan, et al.
Clinics in Dermatology|May 11, 2021
Shedding light on therapeutics in alopecia and their relevance to COVID-19Nicole Fagan, Nekma Meah, Katherine York, et al.
The Australasian Journal of Dermatology|May 11, 2026
Alopecia Areata Prevalence in Australia: Insights From a Nationally Representative Cross-Sectional Survey StudyRodney Sinclair, Samantha Eisman, Leona Yip, et al.
Pageof 26